SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-003417
Filing Date
2014-05-15
Accepted
2014-05-15 16:55:33
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0314_myoscorporation.htm 10-Q 1074391
2 CERTIFICATION f10q0314ex31i_myoscorp.htm EX-31.1 13503
3 CERTIFICATION f10q0314ex31ii_myoscorp.htm EX-31.2 13550
4 CERTIFICATION f10q0314ex32i_myoscorp.htm EX-32.1 7415
5 CERTIFICATION f10q0314ex32ii_myoscorp.htm EX-32.2 7774
  Complete submission text file 0001213900-14-003417.txt   9698179

Data Files

Seq Description Document Type Size
6 atth-20140331.xml EX-101.INS 1660431
7 atth-20140331.xsd EX-101.SCH 78029
8 atth-20140331_cal.xml EX-101.CAL 39641
9 atth-20140331_def.xml EX-101.DEF 288523
10 atth-20140331_lab.xml EX-101.LAB 588004
11 atth-20140331_pre.xml EX-101.PRE 429168
Mailing Address 45 HORSEHILL ROAD SUITE 106 CEDAR KNOLLS NJ 07927
Business Address 45 HORSEHILL ROAD SUITE 106 CEDAR KNOLLS NJ 07927 973-509-0444
MYOS Corp (Filer) CIK: 0001402479 (see all company filings)

IRS No.: 208758875 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53298 | Film No.: 14848469
SIC: 2834 Pharmaceutical Preparations